Manufacturer of Controlled Substances; Notice of Registration; Siemens Healthcare Diagnostics, Inc., 31390 [2012-12822]
Download as PDF
<![CDATA[
31390
Federal Register / Vol. 77, No. 102 / Friday, May 25, 2012 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Pcas-Nanosyn, LLC
By Notice dated January 30, 2012, and
published in the Federal Register on
February 6, 2012, 77 FR 5847, PCASNanosyn, LLC, 3331–B Industrial Drive,
Santa Rosa, California 95403, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–12820 Filed 5–24–12; 8:45 am]
BILLING CODE 4410–09–P
Schedule
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Phencyclidine (7471) ....................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Morphine (9300) ...........................
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
DEPARTMENT OF JUSTICE
II
II
II
II
II
II
II
II
II
II
II
II
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Siemens Healthcare Diagnostics, Inc.
The company is a contract
manufacturer. At the request of the
company’s customers, it manufactures
derivatives of controlled substances in
bulk form only.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
PCAS-Nanosyn, LLC. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated PCAS-Nanosyn, LLC. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
By Notice dated January 26, 2012, and
published in the Federal Register on
February 6, 2012, 77 FR 5847, Siemens
Healthcare Diagnostics Inc., 100 GBC
Drive, Mail Stop 514, Newark, Delaware
19702, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
Tetrahydrocannabinols (7370) .....
Ecgonine (9180) ...........................
Morphine (9300) ...........................
I
II
II
The company plans to produce the
listed controlled substances in bulk to
be used in the manufacture of reagents
and drug calibrator controls which are
DEA exempt products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Siemens Healthcare Diagnostics Inc., to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Siemens Healthcare
Diagnostics Inc., to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–12822 Filed 5–24–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Sigma Aldrich Research Biochemicals,
Inc.
By Notice dated January 26, 2012, and
published in the Federal Register on
February 6, 2012, 77 FR 5847, Sigma
Aldrich Research Biochemicals, Inc., 1–
3 Strathmore Road, Natick,
Massachusetts 01760–2447, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
4-methyl-N-methylcathinone (1248) ............................................................................................................................................................
Aminorex (1585) ..........................................................................................................................................................................................
Alpha-ethyltryptamine (7249) ......................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
3,4-methylenedioxypyrovalerone (7535) .....................................................................................................................................................
3,4-methylenedioxy-N-methylcathinone (7540) ...........................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
4–Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................
4–Bromo-2,5-dimethoxyphenethylamine (7392) .........................................................................................................................................
2,5–Dimethoxyamphetamine (7396) ...........................................................................................................................................................
3,4–Methylenedioxyamphetamine (7400) ...................................................................................................................................................
N–Hydroxy-3,4-methylenedioxyamphetamine (7402) .................................................................................................................................
3,4–Methylenedioxy-N-ethylamphetamine (7404) .......................................................................................................................................
3,4–Methylenedioxymethamphetamine (7405) ...........................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
VerDate Mar<15>2010
17:55 May 24, 2012
Jkt 226001
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
E:\FR\FM\25MYN1.SGM
25MYN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Page 31390]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12822]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Siemens Healthcare Diagnostics, Inc.
By Notice dated January 26, 2012, and published in the Federal
Register on February 6, 2012, 77 FR 5847, Siemens Healthcare
Diagnostics Inc., 100 GBC Drive, Mail Stop 514, Newark, Delaware 19702,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the following basic
classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Ecgonine (9180)............................ II
Morphine (9300)............................ II
------------------------------------------------------------------------
The company plans to produce the listed controlled substances in
bulk to be used in the manufacture of reagents and drug calibrator
controls which are DEA exempt products.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Siemens Healthcare Diagnostics Inc., to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated Siemens Healthcare Diagnostics Inc.,
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in
accordance with 21 CFR 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled
substances listed.
Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-12822 Filed 5-24-12; 8:45 am]
BILLING CODE 4410-09-P
